A South American company just pumped the first crude out of the Western hemisphere's largest oil discovery in 30 years. Reserves are worth an estimated $560 billion at today's prices! And shares are likely to take off. To get the full details on this stock, and two other explosive companies, go here.
Blockbuster (NYSE: BBI) – Another Nail In The Coffin
Can you hear that, Blockbuster (NYSE: BBI)? It’s the sound of obsolescence.
With the news that LG Electronics will be producing high-definition televisions that will stream movies from Netflix (Nasdaq: NFLX), you can add another nail in the coffin for Blockbuster.
At first, Netflix’s threat to Blockbuster seemed laughable. But now, with more consumers cutting back and looking for instant entertainment, low monthly costs and the ease of Netflix are really starting to squeeze Blockbuster.
And that’s not to say that Blockbuster hasn’t given its rivals a hand. There was the misguided and disastrous attempt to merge with financial-albatross Circuit City (OTC: CCTYQ), the botched roll-out of the “no more late fees – just other fees” program and the complete failure to see how a vindictive fee and collection system could alienate its customers.
But the competition isn’t just coming from Netflix. Redbox’s easy-to-use, dollar-a-day rental system is also stealing revenue. Most Redbox vending machines are located outside of parent company McDonald’s (NYSE: MCD) and inside grocery stores. Often in the same shopping centers as Blockbuster.
In the same way Eastman Kodak (NYSE: EK) missed the advent of digital, Blockbuster missed the transformative power of the Internet and subscription rentals. It’s playing catch-up. And only time will tell if BBI can recover.
Companies mentioned in this article: BBI, NFLX, CCTYQ, MCD and EK.
- NFLX: The Netflix Index
- Will Frugality Remain?
- Coinstar Inc. (Nasdaq: CSTR): The Perfect Stock for Bulls & Bears
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed